# Lexaria Bioscience (LEXX) — News

LEXX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lexx/news

## Recent headlines

- [Lexaria Bioscience - MTA to investigate co's DehydraTech technology with proprietary PegBio molecule under development for GLP-1 industry](https://www.ainvest.com/news/lexaria-bioscience-mta-investigate-dehydratech-technology-proprietary-pegbio-molecule-development-glp-1-industry-2608) — AInvest Wire, Aug 13, 2026
- [Lexaria Bioscience Corp - enters a material transfer agreement with PegBio](https://www.ainvest.com/news/lexaria-bioscience-corp-enters-material-transfer-agreement-pegbio-2608) — AInvest Wire, Aug 13, 2026
- [Lexaria Bioscience Corp - reverse stock split effective August 3, 2026 - SEC filing](https://www.ainvest.com/news/lexaria-bioscience-corp-reverse-stock-split-effective-august-3-2026-sec-filing-2607) — AInvest Wire, Jul 30, 2026
- [Lexaria Bioscience Corp - authorizes 1-for-15 reverse stock split - SEC filing](https://www.ainvest.com/news/lexaria-bioscience-corp-authorizes-1-15-reverse-stock-split-sec-filing-2607) — AInvest Wire, Jul 30, 2026
  Lexaria Bioscience Corp. has authorized a 1-for-15 reverse stock split , as disclosed in a recent SEC filing. This corporate action is intended to bring the company’s stock into compliance with the minimum share price requirements of its exchange. The reverse stock split will reduce the total…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).